As of the final cut off for temporary approval it got up to 11 companies (plus a few more selling specialised needs formula).
The list is here https://www.fda.gov/food/infant-formula-guidance-documents-regulatory-information/enforcement-discretion-manufacturers-increase-infant-formula-supplies
However you can see that of those 11, 8 ended up seeking permanent approval which is fewer than I thought. A few of the others were just international subsidaries of Abbott who didn't really need approval.
One is also Care A2+ which I suspect will fold at some point.
Ann: Bubs Q2 FY24 Quarterly Activity and Cashflow Statement, page-24
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.005(3.57%) |
Mkt cap ! $120.5M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.8¢ | 13.0¢ | $314.7K | 2.366M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 351300 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 1626159 | 43 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| BUB (ASX) Chart |